Total Equity - Accelerate Diagnostics Inc (NASDAQ:AXDX) - Alpha Spread

Accelerate Diagnostics Inc
NASDAQ:AXDX

Watchlist Manager
Accelerate Diagnostics Inc Logo
Accelerate Diagnostics Inc
NASDAQ:AXDX
Watchlist
Price: 1.476 USD 0.41% Market Closed
Market Cap: 34.9m USD
Have any thoughts about
Accelerate Diagnostics Inc?
Write Note

Accelerate Diagnostics Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Accelerate Diagnostics Inc
Total Equity Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Accelerate Diagnostics Inc
NASDAQ:AXDX
Total Equity
-$34.9m
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Total Equity
$25.9B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
17%
Boston Scientific Corp
NYSE:BSX
Total Equity
$20.4B
CAGR 3-Years
9%
CAGR 5-Years
17%
CAGR 10-Years
12%
Stryker Corp
NYSE:SYK
Total Equity
$19.8B
CAGR 3-Years
13%
CAGR 5-Years
11%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Total Equity
$39.3B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
5%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Equity
$14.7B
CAGR 3-Years
11%
CAGR 5-Years
15%
CAGR 10-Years
18%

See Also

What is Accelerate Diagnostics Inc's Total Equity?
Total Equity
-34.9m USD

Based on the financial report for Jun 30, 2024, Accelerate Diagnostics Inc's Total Equity amounts to -34.9m USD.

What is Accelerate Diagnostics Inc's Total Equity growth rate?
Total Equity CAGR 3Y
21%

Over the last year, the Total Equity growth was 10%. The average annual Total Equity growth rates for Accelerate Diagnostics Inc have been 21% over the past three years .

Back to Top